Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Generative AI writes code in seconds, but leaders who can't think like programmers won't go very far. Computational thinking ...

点击上方“Deephub Imba”,关注公众号,好文章不错过 !AutoGen 是微软研究院开源的多智能体 AI 系统框架。这个框架的设计思路很简单——让多个 AI ...